JPRN-UMIN000007515已完成未知
Pilot study of sorafenib for RET fusion positive non-small cell lung cancer - Sorafenib for RET fusion positive non-small cell lung cancer
Japanese Foundation for Cancer Research Cancer Institute Hospital0 个研究点目标入组 3 人开始时间: 2012年3月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Serious complications 2)Brain metastases need raidotherapy 3)Subjects with interstitial pneumonia or pulmonary fibrosis by chest X-ray 4)Patients who can not take orally. 5)Patients who have serious hypersensitivity reaction. 6)Patients who receive prohibited treatments. 7)Pregnancy, breast feeding or wish of future bearing 8)Concurrent use of steriod therapy except for topical or inhaled 9)Active infectious disease 10)Pleural effusion, peritoneal fluid, and pericardial fluid need drainage therapy 11)Patients whose participation in the trial is judged to be inappropriate by the attending doctor
研究者
相似试验
已完成
不适用
Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancerhepatoblastoma and hepatocellular carcinoma of childrenJPRN-UMIN000022324Kanagawa Children's Medical Center12
已完成
不适用
Pilot Study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancerJPRN-UMIN000021931Kanagawa children's medical center12
已完成
1 期
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsAdvanced Malignant NeoplasmBRAF Gene MutationMetastatic Malignant NeoplasmRecurrent Malignant NeoplasmRefractory Malignant NeoplasmNCT01531361M.D. Anderson Cancer Center46
招募中
2 期
Phase II study of sorafenib-regorafneib sequential therapy for the patients with advanced hepatocellular carcinoma previously treated with lenvatinibHepatocellular carcinomaJPRN-jRCT1041190082Yamashita Tatsuya33
招募中
3 期
Sorafenib (Soranex)® for prevention of relapse in AML PatientsAcute myeloblastic leukemiaIRCT20140818018842N21Tehran University of Medical Sciences20